Numerous studies have highlighted the role of PTX3 promoter methylation in tumor progression (29, 30, 32, 96), suggesting that drugs targeting DNA methylation could help mitigate tumor progression, particularly in cancers of the digestive system. Here, PTX3 is linked to digestive system cancer.